ArticleCase reports in otolaryngology2026
Facial Nerve Hemangioma in the Internal Auditory Canal: A Rare Localization and Therapeutic Challenge.
Article in Case reports in otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Facial nerve hemangiomas (FNHs) are rare vascular tumors that often mimic other facial nerve disorders, making diagnosis and management challenging. This report highlights a case of FNH in the internal auditory canal (IAC) successfully treated via a translabyrinthine approach. Case Presentation: A 64-year-old female patient with a history of squamous cell carcinoma of the tongue presented with progressive left-sided peripheral facial paralysis (House-Brackmann Grade IV), associated with ipsilateral hearing loss and vertigo. MRI revealed a nodular lesion in the IAC with imaging features suggestive of a vascular origin. Due to symptom severity, surgical excision was performed using a translabyrinthine approach. Intraoperatively, a vascular lesion compressing but not infiltrating the facial nerve was excised, and histopathology confirmed FNH. Results: The patient showed significant postoperative improvement, with facial nerve function improving to House-Brackmann Grade II at 6 months. Conclusion: Early recognition and surgical intervention for symptomatic FNHs can prevent further neurological impairment. The translabyrinthine approach offers effective tumor removal while preserving facial nerve integrity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.